Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [31] Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal
    Rowe, A. Shaun
    Dietrich, Scott K.
    Phillips, John W.
    Foster, Kaci E.
    Canter, Joshua R.
    CRITICAL CARE MEDICINE, 2018, 46 (06) : 943 - 948
  • [32] Outcomes Associated With 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients
    Highsmith, Emily A.
    Morton, Celia
    Varnado, Sara
    Donahue, Kevin R.
    Sulhan, Suraj
    Lista, Annette
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (05): : 598 - 605
  • [33] Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
    Schulman, Sam
    Gross, Peter L.
    Ritchie, Bruce
    Nahirniak, Susan
    Lin, Yulia
    Lieberman, Lani
    Carrier, Marc
    Crowther, Mark A.
    Ghosh, Indy
    Lazo-Langner, Alejandro
    Zondag, Michelle
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (05) : 842 - 851
  • [34] Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries
    Grace E. Cooksey
    Leslie A. Hamilton
    James C. McMillen
    Jared H. Griffard
    A. Shaun Rowe
    Neurocritical Care, 2022, 37 : 471 - 478
  • [35] Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries
    Cooksey, Grace E.
    Hamilton, Leslie A.
    McMillen, James C.
    Griffard, Jared H.
    Rowe, A. Shaun
    NEUROCRITICAL CARE, 2022, 37 (02) : 471 - 478
  • [36] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [37] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR THE REVERSAL OF DIRECT ORAL ANTICOAGULANTS
    Zada, Ilanit
    Wang, Shan
    Akerman, Meredith
    Hanna, Adel
    CRITICAL CARE MEDICINE, 2020, 48
  • [38] Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants
    Zada, Ilanit
    Wang, Shan
    Akerman, Meredith
    Hanna, Adel
    JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (01) : 58 - 62
  • [39] Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate
    Peksa, Gary D.
    Mokszycki, Robert K.
    Rech, Megan A.
    Maynard, Brian
    Panos, Nicholas G.
    Sweis, Rolla T.
    DeMott, Joshua M.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 207 - 215
  • [40] Prospective Trial of Fixed-Dose 4-Factor Prothrombin Complex Concentrate for Emergent Reversal of Warfarin in a Level One Trauma Center
    Peters, J. M.
    Gorlin, J. B.
    Klein, L.
    Perry, E. H.
    TRANSFUSION, 2015, 55 : 25A - 26A
12345